Valuation (67%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 7.15 | N/A |
| PEG Ratio (TTM) | 14.51 | N/A |
| P/S Ratio (TTM) | 0.53 | N/A |
| P/B Ratio (TTM) | 0.91 | N/A |
| P/FCF Ratio (TTM) | -6.31 | N/A |
| Price to 5YR AVG Earnings Ratio | 7.53 | N/A |
| Price to 5YR AVG FCF Ratio | 55.17 | N/A |
Profitability (35%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 6.74% | N/A |
| ROE (TTM) | 13.13% | N/A |
| Net Profit Margin (TTM) | 7.44% | N/A |
| ROIC 5YR AVG | 16.24% | N/A |
Growth (82%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 2.99% | 74.03% | 36.29% |
| Revenue | 8.31% | 25.38% | 12.99% |
| Net Income | 2.39% | 80.47% | 39.22% |
| Cash Flow | -775.63% | 166.91% | 134.14% |
Health (49%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 5.71 | N/A |
| Quick Ratio (TTM) | 0.89 | N/A |
| D/E Ratio (TTM) | 0.70 | N/A |
| Interest Coverage (TTM) | N/A | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 3.29 | N/A |
| LTL to 5YR AVG FCF | 25.09 | N/A |
| Shares Outstanding Growth 5YR AVG | 1.27% | N/A |